title: [Perioperative therapy with thienopyridines in coronary artery bypass surgery].
abstract: The number of patients taking dual antiplatelet therapy is growing with high cardiovascular risk associated with even short-time antiplatelets cessation in some clinical scenarios (e.g., after acute coronary syndrome or percutaneous coronary interventions). However, sometimes, it is required to hold antiplatelets particularly in the preoperative period of coronary artery bypass surgery (CABG). The article reviews the data on thienopyridine use before CABG, offers an algorithm of preoperative antiplatelet therapy depending on patient's cardiovascular risk.
authors.forename: S S
authors.initials: SS
authors.lastname: Altarev
authors.forename: K E
authors.initials: KE
authors.lastname: Krivoshapova
authors.forename: O L
authors.initials: OL
authors.lastname: Barbarash
mesh_terms: D000465:Algorithms; D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000601:surgery; D002986:Clinical Trials as Topic; D001026:Coronary Artery Bypass / Q000009:adverse effects / Q000379:methods; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology; D011183:Postoperative Complications / Q000517:prevention & control*; D011300:Preoperative Care / Q000379:methods; D020379:Risk Adjustment; D058924:Thienopyridines / Q000494:pharmacology*
chemical_list: D010975:Platelet Aggregation Inhibitors; D058924:Thienopyridines